# GHK-Cu Research: Skin, Hair, Wound, and Gene-Expression Studies > GHK-Cu research indexed by domain: collagen and skin trials, the ALAVAX hair-count RCT, wound-healing models, and the gene-expression signature. Every quantitative claim cited to its paper. Skin and collagen, hair growth, wound healing, gene expression, and neuroprotection — read for what they establish and where they stop, each tied to its source. ## Copper Peptide Skin Research: Collagen and Elasticity The skin record is the deepest part of the GHK-Cu literature. The canonical skin-regeneration review describes GHK-Cu stimulating fibroblast synthesis of collagen, dermatan sulfate, chondroitin sulfate, and the proteoglycan decorin, with placebo-controlled improvements in skin laxity, clarity, fine lines, wrinkle depth, and density [3]. The same review reports that topical GHK-Cu increased collagen production in 70% of treated women, versus 50% for vitamin C and 40% for retinoic acid [3]. What the skin section cannot promise is effortless delivery. A human skin-penetration study recorded a copper permeability coefficient of 2.43 x 10^-4 cm/h, with 136.2 ug/cm^2 of copper permeating over 48 hours and 97 ug/cm^2 retained as a dermal depot [5]. The depot is the useful part — prolonged local availability — but it confirms that native GHK-Cu penetrates a stratum corneum slowly, which is why novel delivery systems exist. This is the [copper peptide skin research](/research) that the marketing language usually skips. ## Copper Peptide Benefits Documented in Studies Read at the level of the foundational tissue-remodeling review, the documented copper peptide benefits cluster into four groups. First, matrix synthesis: collagen, elastin, glycosaminoglycans, and decorin [3][6]. Second, angiogenic and growth-factor signaling: increased VEGF, FGF-2, NGF, and neurotrophins 3 and 4 [6]. Third, antioxidant and anti-inflammatory action: suppression of free radicals, thromboxane, TGF-beta-1, and TNF-alpha [6]. Fourth, matrix-remodeling control through MMP/TIMP balance rather than unchecked degradation [7]. The honest framing is that this is a benefit profile observed largely in cell culture, rodent models, and small topical human trials. The breadth is real and reproducible across models; the controlled human efficacy data is narrower than the mechanism list, and this dossier keeps those two facts side by side. ## Copper Peptide Hair Growth Research Copper peptide hair growth research has both an animal foundation and one controlled human signal. The animal basis: peptide-copper complexes stimulated hair-follicle activity in C3H mice, an early model for copper-peptide hair work [13]. The human signal: a 6-month trial in 45 men with androgenetic alopecia (Norwood-Hamilton II to V) of a complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide (ALAVAX) increased hair count by 52.6 at 100 mg/mL and 71.5 at 50 mg/mL, versus 9.6 for placebo (p<0.05), with no adverse events in any group [4]. The load-bearing caveat is in the formulation name. ALAVAX is a 5-ALA + GHK combination, not pure GHK-Cu, so the trial demonstrates the combination, not the monotherapy. There is no equivalent human RCT of pure GHK-Cu for hair. This is the [copper peptide hair growth research](/research) read accurately rather than optimistically. ## Wound healing and angiogenesis GHK-Cu stimulates wound healing across numerous models, increasing collagen, elastin, metalloproteinases, anti-proteases, VEGF, FGF-2, NGF, neurotrophins 3 and 4, and erythropoietin, while suppressing free radicals, thromboxane, TGF-beta-1, TNF-alpha, and protein glycation and chemoattracting repair cells [6]. The angiogenic component traces partly to SPARC-derived GHK/KGHK peptides [8]. Biomaterial delivery extends the wound work. A biotinylated-GHK collagenous matrix accelerated dermal wound healing in rats [12], and a photo-crosslinkable hyaluronic-acid hydrogel embedded with GHK-Cu peptide nanofibers accelerated wound closure with densely remodeled collagen and enhanced VEGF-driven angiogenesis, outperforming non-lipidated GHK and EGF comparators for fibroblast proliferation and migration [14]. These are [GHK-Cu wound healing studies](/research), and they remain predominantly preclinical. ## GHK-Cu gene expression and neuroprotection The gene-expression work is the most ambitious mechanism in the file. Connectivity Map analysis reports GHK altering expression of about 31.2% of human genes at a 50%-or-greater change threshold, with strong upregulation of the ubiquitin-proteasome system and of DNA-repair and antioxidant gene sets [2]. This is the basis of the [GHK-Cu gene expression research](/research) that drives the anti-aging framing — and it is bioinformatic, needing protein-level confirmation. The neuroprotection signal is earlier still and entirely in rodents. GHK and its analogs produced anxiolytic effects in rats [10], and the tripeptide reduced pain-induced aggressive-defensive behavior [11]. These are behavioral animal findings obtained by intraperitoneal dosing, not evidence of a validated human central-nervous-system pathway. ## Copper Peptide vs Retinol: Comparative Research A 2025 anti-wrinkle review reports procollagen synthesis increased in 70% of GHK-Cu-treated subjects versus 50% for vitamin C and 40% for retinoic acid [9]. The two actives work through different pathways — GHK-Cu via fibroblast matrix synthesis and copper-dependent remodeling, retinoids via retinoic-acid-receptor signaling — and direct head-to-head trials are limited. The comparison is endpoint-dependent, and 'better' is not established by this single review. --- A feature dossier on the copper tripeptide GHK-Cu, set like a magazine and sourced like a citation index — every figure attributed, every gap printed in plain sight, and nothing here clinical, prescribed, or for sale.